Patent · US Expired

Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor

US6465458B1 · kind B1 · utility

19Cited by
12References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 2000
Grant dateOct 15, 2002
Priority date
Expiry dateJun 22, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of norepinephrine is a benefit are disclosed. The methods comprise administering the optically pure (S,S) enantiomer of reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.